These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 131398)

  • 1. The Distinguished Lecture. Is hypertension essential?
    Liddle GW
    Trans Assoc Am Physicians; 1975; 88():55-69. PubMed ID: 131398
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical usefulness of saralasin in human hypertension (author's transl)].
    Fouchard M; Bichara M; Grüfeld JP; Barbanel C; Meyer P; Funck-Brentano JL
    Nouv Presse Med; 1978 Feb; 7(7):539-43. PubMed ID: 643579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What role does the renin-angiotensin system have in the pathogenesis of hypertension?].
    Gross F; Dietz R; Lüth JB; Mann JF
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():177-87. PubMed ID: 613563
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of renin and angiotensin in hypertension.
    Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Padfield PL; Semple PF; Robertson JI
    Cardiovasc Clin; 1978; 9(1):55-89. PubMed ID: 352522
    [No Abstract]   [Full Text] [Related]  

  • 5. [Importance of renin-angiotensin-aldosterone system in diverse forms of hypertension].
    Werning C; Weidmann P; Vetter W; Stiel D; Schweikert HU; Siegenthaler W
    Schweiz Rundsch Med Prax; 1970 May; 59(20):730-7. PubMed ID: 4321141
    [No Abstract]   [Full Text] [Related]  

  • 6. [The reinin- angiotensin-aldosterone system in essential and renovascular hypertension].
    Tronchetti F; Romanelli R; Materazzi F; Cella PL; Salvetti A
    Pathol Biol; 1968 May; 16(9):575-81. PubMed ID: 4300851
    [No Abstract]   [Full Text] [Related]  

  • 7. [Spironolactone-induced changes of the renin-angiotensin-aldosterone system and blood pressure lowering in essential hypertension].
    Furrer J; Vetter W; Nussberger J; Beckerhoff R; Siegenthaler W
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():235-6. PubMed ID: 349929
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renin, angiotensin, aldosterone and arterial hypertension. II].
    Maxwell MH
    Presse Med (1893); 1969 Dec; 77(55):2107-10. PubMed ID: 4313755
    [No Abstract]   [Full Text] [Related]  

  • 10. [Abnormal secretion of renin: theoretical and practical repercussions on renovascular hypertension].
    Menard J; Ulmann A; Fressinaud P; Corvol P
    Rev Med Suisse Romande; 1974 Aug; 94(8):629-39. PubMed ID: 4373811
    [No Abstract]   [Full Text] [Related]  

  • 11. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
    Espiner EA; Mansfield H; Miles K
    N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
    [No Abstract]   [Full Text] [Related]  

  • 12. [The significance of the renin-angiotensin system in renovascular hypertension].
    Gastaldi L; Martegani M; Piatti L
    Minerva Med; 1975 Nov; 66(79):4135-8. PubMed ID: 1196500
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical physiopathology of certain forms of secondary arterial hypertension].
    Veyrat R
    Schweiz Med Wochenschr; 1973 Nov; 103(47):1653-62. PubMed ID: 4356590
    [No Abstract]   [Full Text] [Related]  

  • 14. [Physiopathology and diagnosis of renal hypertonus].
    Börner H
    Z Arztl Fortbild (Jena); 1973 Nov; 67(22):1146-9. PubMed ID: 4359665
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma renin activity in hypertension.
    Oparil S
    Compr Ther; 1975 Dec; 1(8):57-64. PubMed ID: 1222561
    [No Abstract]   [Full Text] [Related]  

  • 16. [Physiopathology of renovascular hypertension].
    Veyrat R
    Radiol Clin Biol; 1968; 37(4):194-208. PubMed ID: 4306812
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess.
    Beevers DG; Brown JJ; Ferriss JB; Fraser R; Lever AF; Robertson JI
    Am Heart J; 1973 Sep; 86(3):404-14. PubMed ID: 4592546
    [No Abstract]   [Full Text] [Related]  

  • 18. Outpatient experience with saralasin.
    Streeten DH; Anderson GH
    Kidney Int Suppl; 1979 Mar; (9):S44-52. PubMed ID: 289863
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-renin-mediated renovascular hypertension: A new syndrome?
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1977 Mar; 1(8012):615-7. PubMed ID: 66424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aetiology and pathogenesis of chronic arterial hypertension].
    Klaus D
    Munch Med Wochenschr; 1970 Oct; 112(41):1846-57. PubMed ID: 4319196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.